Q32 Bio’s bempikibart shows signs of a remittive effect in alopecia areata—Here’s what that means

Pallavi Madhiraju- March 9, 2025 0

Q32 Bio Inc. has released promising SIGNAL-AA trial results, shedding new light on the potential of bempikibart clinical data as an innovative alopecia areata treatment. ... Read More

Longeveron 2024 revenue jumps 237%, eyes FDA approval for Lomecel-B

Pallavi Madhiraju- March 1, 2025 0

Longeveron Inc., a biotechnology company specializing in regenerative medicine, has reported significant financial progress alongside major advancements in its investigational stem cell therapy, Lomecel-B. The ... Read More

4D Molecular Therapeutics strengthens cash position, eyes Phase 3 success for 4D-150

Pallavi Madhiraju- March 1, 2025 0

4D Molecular Therapeutics (4DMT) has announced its full-year 2024 financial results, highlighting key advancements in its late-stage clinical pipeline. With a primary focus on its ... Read More

Praxis Precision Medicines faces major setback in ulixacaltamide trial but remains committed to Essential3 study

Pallavi Madhiraju- February 28, 2025 0

Praxis Precision Medicines (NASDAQ: PRAX), a clinical-stage biopharmaceutical company specializing in treatments for central nervous system disorders, encountered a significant challenge as an independent data ... Read More

Recce Pharmaceuticals advances R327 Gel towards Phase 3 after promising Phase II trial

Pallavi Madhiraju- February 17, 2025 0

Recce Pharmaceuticals Limited has announced significant success in its Phase II trial of RECCE 327 topical gel (R327G), a synthetic anti-infective designed to treat acute ... Read More

Wockhardt’s Zaynich achieves record-breaking 96.8% clinical cure rate in cUTI Phase III trial

Pallavi Madhiraju- January 31, 2025 0

Wockhardt Limited has announced a major breakthrough in the treatment of complicated urinary tract infections (cUTI) with its novel antibiotic Zaynich (Zidebactam/Cefepime, WCK 5222). In ... Read More

CliniOps and Indegene partner to redefine clinical trial efficiency with digital innovation

Pallavi Madhiraju- January 10, 2025 0

CliniOps, a leading innovator in advanced digital clinical trial solutions, has entered into a strategic partnership with Indegene, a digital-first life sciences commercialization company. This ... Read More

Swiss biotech company Noema Pharma secures CHF130m to advance CNS therapies

Pallavi Madhiraju- December 15, 2024 0

Basel, Switzerland-based Noema Pharma, a clinical-stage biotech company, has announced the successful close of its Series B financing round extension, securing CHF 130 million (approximately ... Read More

Merck’s WELIREG receives positive CHMP opinion for VHL tumours and advanced RCC

Pallavi Madhiraju- December 13, 2024 0

Merck, known as MSD outside the U.S. and Canada, has moved a step closer to offering innovative treatment options in Europe. The European Medicines Agency’s ... Read More

Actinogen Medical progresses in XanaMIA Phase 2b/3 trial for Alzheimer’s disease

Pallavi Madhiraju- December 9, 2024 0

Actinogen Medical Limited (ASX: ACW) has announced a major milestone in its ongoing XanaMIA Phase 2b/3 clinical trial, aimed at treating biomarker-positive mild to moderate ... Read More

123...810 / 75 Posts